Cargando…
Combination coating of chitosan and anti-CD34 antibody applied on sirolimus-eluting stents can promote endothelialization while reducing neointimal formation
BACKGROUND: Circulating endothelial progenitor cells (EPCs) capture technology improves endothelialization rates of sirolimus-eluting stents (SES), but the problem of delayed re-endothelialization, as well as endothelial dysfunction, has still not been overcome. Therefore, we investigated whether th...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506512/ https://www.ncbi.nlm.nih.gov/pubmed/23098083 http://dx.doi.org/10.1186/1471-2261-12-96 |
_version_ | 1782250919096745984 |
---|---|
author | Yang, Feng Feng, Shi-Chao Pang, Xiang-Jun Li, Wei-Xiao Bi, Yong-Hua Zhao, Qian Zhang, Shi-Xuan Wang, Yang Feng, Bo |
author_facet | Yang, Feng Feng, Shi-Chao Pang, Xiang-Jun Li, Wei-Xiao Bi, Yong-Hua Zhao, Qian Zhang, Shi-Xuan Wang, Yang Feng, Bo |
author_sort | Yang, Feng |
collection | PubMed |
description | BACKGROUND: Circulating endothelial progenitor cells (EPCs) capture technology improves endothelialization rates of sirolimus-eluting stents (SES), but the problem of delayed re-endothelialization, as well as endothelial dysfunction, has still not been overcome. Therefore, we investigated whether the combination coating of hyaluronan-chitosan (HC) and anti-CD34 antibody applied on an SES (HCASES) can promote endothelialization, while reducing neointimal formation and inflammation. METHODS: Sirolimus-eluting stents(SES), anti-CD34 antibody stents (GS) and HC-anti-CD34 antibody combined with sirolimus-eluting stents (HCASES) were deployed in 54 normal porcine arteries and harvested for scanning electron microscopy (SEM) and histological analysis. The ratio of endothelial coverage above the stents was evaluated by SEM analysis at 7, 14 and 28 days. The percentage of in-stent stenosis was histologically analyzed at 14 and 28 days. RESULTS: SEM analysis at 7 days showed that endothelial strut coverage was increased in the HCASES group (68±7%) compared with that in the SES group (31±4%, p=0.02). At 14 days, stent surface endothelialization, evaluated by SEM, showed a significantly higher extent of endothelial coverage above struts in the GS (95 ± 2%) and the HCASES groups (87±4%) compared with that in the SES group (51±6%, p=0.02). Histological examination showed that the percentage of stenosis in the HCASES group was not significantly different to that of the SES and GS groups (both p> 0.05). At 28 days, there was no difference in the rates of endothelial coverage between the HCASES and GS groups. The HCASES group showed less stenosis than that in the GS group (P < 0.05), but it was not significantly different from the SES group (P=0.068). CONCLUSIONS: SEM and histology demonstrated that HCASESs can promote re-endothelialization while enhancing antiproliferative effects. |
format | Online Article Text |
id | pubmed-3506512 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35065122012-11-27 Combination coating of chitosan and anti-CD34 antibody applied on sirolimus-eluting stents can promote endothelialization while reducing neointimal formation Yang, Feng Feng, Shi-Chao Pang, Xiang-Jun Li, Wei-Xiao Bi, Yong-Hua Zhao, Qian Zhang, Shi-Xuan Wang, Yang Feng, Bo BMC Cardiovasc Disord Research Article BACKGROUND: Circulating endothelial progenitor cells (EPCs) capture technology improves endothelialization rates of sirolimus-eluting stents (SES), but the problem of delayed re-endothelialization, as well as endothelial dysfunction, has still not been overcome. Therefore, we investigated whether the combination coating of hyaluronan-chitosan (HC) and anti-CD34 antibody applied on an SES (HCASES) can promote endothelialization, while reducing neointimal formation and inflammation. METHODS: Sirolimus-eluting stents(SES), anti-CD34 antibody stents (GS) and HC-anti-CD34 antibody combined with sirolimus-eluting stents (HCASES) were deployed in 54 normal porcine arteries and harvested for scanning electron microscopy (SEM) and histological analysis. The ratio of endothelial coverage above the stents was evaluated by SEM analysis at 7, 14 and 28 days. The percentage of in-stent stenosis was histologically analyzed at 14 and 28 days. RESULTS: SEM analysis at 7 days showed that endothelial strut coverage was increased in the HCASES group (68±7%) compared with that in the SES group (31±4%, p=0.02). At 14 days, stent surface endothelialization, evaluated by SEM, showed a significantly higher extent of endothelial coverage above struts in the GS (95 ± 2%) and the HCASES groups (87±4%) compared with that in the SES group (51±6%, p=0.02). Histological examination showed that the percentage of stenosis in the HCASES group was not significantly different to that of the SES and GS groups (both p> 0.05). At 28 days, there was no difference in the rates of endothelial coverage between the HCASES and GS groups. The HCASES group showed less stenosis than that in the GS group (P < 0.05), but it was not significantly different from the SES group (P=0.068). CONCLUSIONS: SEM and histology demonstrated that HCASESs can promote re-endothelialization while enhancing antiproliferative effects. BioMed Central 2012-10-26 /pmc/articles/PMC3506512/ /pubmed/23098083 http://dx.doi.org/10.1186/1471-2261-12-96 Text en Copyright ©2012 Yang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Yang, Feng Feng, Shi-Chao Pang, Xiang-Jun Li, Wei-Xiao Bi, Yong-Hua Zhao, Qian Zhang, Shi-Xuan Wang, Yang Feng, Bo Combination coating of chitosan and anti-CD34 antibody applied on sirolimus-eluting stents can promote endothelialization while reducing neointimal formation |
title | Combination coating of chitosan and anti-CD34 antibody applied on sirolimus-eluting stents can promote endothelialization while reducing neointimal formation |
title_full | Combination coating of chitosan and anti-CD34 antibody applied on sirolimus-eluting stents can promote endothelialization while reducing neointimal formation |
title_fullStr | Combination coating of chitosan and anti-CD34 antibody applied on sirolimus-eluting stents can promote endothelialization while reducing neointimal formation |
title_full_unstemmed | Combination coating of chitosan and anti-CD34 antibody applied on sirolimus-eluting stents can promote endothelialization while reducing neointimal formation |
title_short | Combination coating of chitosan and anti-CD34 antibody applied on sirolimus-eluting stents can promote endothelialization while reducing neointimal formation |
title_sort | combination coating of chitosan and anti-cd34 antibody applied on sirolimus-eluting stents can promote endothelialization while reducing neointimal formation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506512/ https://www.ncbi.nlm.nih.gov/pubmed/23098083 http://dx.doi.org/10.1186/1471-2261-12-96 |
work_keys_str_mv | AT yangfeng combinationcoatingofchitosanandanticd34antibodyappliedonsirolimuselutingstentscanpromoteendothelializationwhilereducingneointimalformation AT fengshichao combinationcoatingofchitosanandanticd34antibodyappliedonsirolimuselutingstentscanpromoteendothelializationwhilereducingneointimalformation AT pangxiangjun combinationcoatingofchitosanandanticd34antibodyappliedonsirolimuselutingstentscanpromoteendothelializationwhilereducingneointimalformation AT liweixiao combinationcoatingofchitosanandanticd34antibodyappliedonsirolimuselutingstentscanpromoteendothelializationwhilereducingneointimalformation AT biyonghua combinationcoatingofchitosanandanticd34antibodyappliedonsirolimuselutingstentscanpromoteendothelializationwhilereducingneointimalformation AT zhaoqian combinationcoatingofchitosanandanticd34antibodyappliedonsirolimuselutingstentscanpromoteendothelializationwhilereducingneointimalformation AT zhangshixuan combinationcoatingofchitosanandanticd34antibodyappliedonsirolimuselutingstentscanpromoteendothelializationwhilereducingneointimalformation AT wangyang combinationcoatingofchitosanandanticd34antibodyappliedonsirolimuselutingstentscanpromoteendothelializationwhilereducingneointimalformation AT fengbo combinationcoatingofchitosanandanticd34antibodyappliedonsirolimuselutingstentscanpromoteendothelializationwhilereducingneointimalformation |